Skin of Color pp 327-350 | Cite as

Dermatologic Disorders in Children of Color



Children of color include a broad variety of ethnic types, skin tones, and genetic backgrounds. Broadly, the grouping includes Black, Hispanic, Asian, Indian, and Middle Eastern children. The United States is referred to as a melting pot, and, indeed, children with genetic backgrounds from the far reaches of the world can be seen in North America due to immigration patterns. These global immigration patterns have helped to introduce both new patterns of disease and new cutaneous infectious diseases into the North American pediatric population. This chapter provides an overview of pediatric dermatologic diseases as they pertain to skin of color. The first section looks at the development of skin and soft tissue structures in children of color, the second examines the presentation of common childhood diseases in children of color, and the third looks specifically at diseases genetically limited to children of color.


Atopic Dermatitis Kawasaki Disease Mycosis Fungoides Black Child Skin Tone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Silverberg NB. Pediatric dermatology in children of color. Access Dermatol, posten online 17 Aug 2010. Accessed 15 March, 2011.Google Scholar
  2. 2.
    Morell R, Carey ML, Lalwani AK, Friedman TB, Asher Jr JH. Three mutations in the paired homeodomain of PAX3 that cause Waardenburg syndrome type 1. Hum Hered. 1997;47:38–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Thong HY, Jee SH, Sun CC, Boissy RE. The patterns of melanosome distribution in keratinocytes of human skin as one determining factor of skin colour. Br J Dermatol. 2003;149:498–505.PubMedCrossRefGoogle Scholar
  4. 4.
    Tsai FJ, Tsai CH. Birthmarks and congenital skin lesions in Chinese newborns. J Formos Med Assoc. 1993;92:838–41.PubMedGoogle Scholar
  5. 5.
    Cordova A. The Mongolian spot: a study of ethnic differences and a literature review. Clin Pediatr. 1981;20:714–9.CrossRefGoogle Scholar
  6. 6.
    Ho SG, Chan HH. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol. 2009;10:153–68.PubMedCrossRefGoogle Scholar
  7. 7.
    Meleti M, Vescovi P, Mooi WJ, van der Waal I. Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:606–16.PubMedCrossRefGoogle Scholar
  8. 8.
    Buka R, Friedman KA, Phelps RG, Silver L, Calero F, Rudikoff D. Childhood longitudinal melanonychia: case reports and review of the literature. Mt Sinai J Med. 2001;68:331–5.PubMedGoogle Scholar
  9. 9.
    Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 2009;18(9):741–9.Google Scholar
  10. 10.
    Laude TA. Skin disorders in black children. Curr Opin Pediatr. 1996;8:381–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Child FJ, Fuller LC, Higgins EM, Du Vivier AW. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol. 1999;141:512–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Kiken DA, Silverberg NB. Atopic dermatitis in children, part 1: epidemiology, clinical features, and complications. Cutis. 2006;78:241–7.PubMedGoogle Scholar
  13. 13.
    Williams HC, Pembroke AC, Forsdyke H, Boodoo G, Hay RJ, Burney PG. London-born black Caribbean children are at increased risk of atopic dermatitis. J Am Acad Dermatol. 1995;32(2 Pt 1):212–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol. 2002;147(5):920–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Williams HC, Pembroke AC. Infraorbital crease, ethnic group, and atopic dermatitis. Arch Dermatol. 1996;132:51–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Kiken DA, Silverberg NB. Atopic dermatitis in children, part 2: treatment options. Cutis. 2006;78:401–6.PubMedGoogle Scholar
  17. 17.
    Rigopoulos D, Gregoriou S, Charissi C, Kontochristopoulos G, Kalogeromitros D, Georgala S. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. Br J Dermatol. 2006;155:152–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Williams JV, Eichenfield LF, Burke BL, Barnes-Eley M, Friedlander SF. Prevalence of scalp scaling in prepubertal children. Pediatrics. 2005;115:e1–6.PubMedGoogle Scholar
  19. 19.
    Elish D, Silverberg NB. Infantile seborrheic dermatitis. Cutis. 2006;77:297–300.PubMedGoogle Scholar
  20. 20.
    High WA, Pandya AG. Pilot trial of 1 % pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation. J Am Acad Dermatol. 2006;54:1083–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: how correct is the “classic” description? Arch Pediatr Adolesc Med. 2007;161:503–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Rasi A, Tajziehchi L, Savabi-Nasab S. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J Drugs Dermatol. 2008;7(1):35–8.PubMedGoogle Scholar
  23. 23.
    Sharma V, Beyer DJ, Paruthi S, Nopper AJ. Prominent pruritic periumbilical papules: allergic contact dermatitis to nickel. Pediatr Dermatol. 2002;19:106–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Silverberg NB, Licht J, Friedler S, Sethi S, Laude TA. Nickel contact hypersensitivity in ­children. Pediatr Dermatol. 2002;19:110–3.PubMedCrossRefGoogle Scholar
  25. 25.
    Moennich JN, Zirwas M, Jacob SE. Nickel-induced facial dermatitis: adolescents beware of the cell phone. Cutis. 2009;84(4):199–200.PubMedGoogle Scholar
  26. 26.
    Bhardwaj SS, Jaimes JP, Liu A, Warshaw EM. A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis. Dermatitis. 2007;18(1):26–31.PubMedCrossRefGoogle Scholar
  27. 27.
    Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, Rolstad T, Margolis DJ. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A. Etanercept pediatric psoriasis study group. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358(3):241–51.PubMedCrossRefGoogle Scholar
  29. 29.
    Pauporte M, Maibach H, Lowe N, Pugliese M, Friedman DJ, Mendelsohn H, Cargill I, Ramirez R. Fluocinolone acetonide topical oil for scalp psoriasis. J Dermatol Treat. 2004;15(6):360–4.CrossRefGoogle Scholar
  30. 30.
    Natarajan S, Milne D, Jones AL, Goodfellow M, Perry J, Koerner RJ. Dietzia strain X: a newly described Actinomycete isolated from confluent and reticulated papillomatosis. Br J Dermatol. 2005;153:825–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Silverberg NB, Heilman ER. Calcipotriene in the therapy of confluent and reticulated papillomatosis of Gougererot and Carteaud. J Clin Derm. 1998;1(4):12–4.Google Scholar
  32. 32.
    Davis MD, Weenig RH, Camilleri MJ. Confluent and reticulate papillomatosis (Gougerot-Carteaud syndrome): a minocycline-responsive dermatosis without evidence for yeast in pathogenesis. A study of 39 patients and a proposal of diagnostic criteria. Br J Dermatol. 2006;154:287–93.PubMedCrossRefGoogle Scholar
  33. 33.
    Solomon BA, Laude TA. Two patients with confluent and reticulated papillomatosis: response to oral isotretinoin and 10 % lactic acid lotion. J Am Acad Dermatol. 1996;35:645–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Hairdressing and the prevalence of scalp disease in African adults. Br J Dermatol. 2007;157:981–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Determinants of marginal traction alopecia in African girls and women. J Am Acad Dermatol. 2008;59:432–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Silverberg NB, Singh A, Laude TA. Cutaneous manifestations of chronic renal failure in children of color. Pediatr Dermatol. 2001;18:199–204.PubMedCrossRefGoogle Scholar
  37. 37.
    Lucky AW, Biro FM, Daniels SR, Cedars MI, Khoury PR, Morrison JA. The prevalence of upper lip hair in black and white girls during puberty: a new standard. J Pediatr. 2001;138:134–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Gathers RC, Lim HW. Central centrifugal cicatricial alopecia: past, present, and future. J Am Acad Dermatol. 2009;60:660–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Miyamoto M, Tsuboi R, Oh-I T. Case of acquired trichorrhexis nodosa: scanning electron microscopic observation. J Dermatol. 2009;36:109–10.PubMedCrossRefGoogle Scholar
  40. 40.
    Bari AU, Khan MB. Dermatological disorders related to cultural practices in black Africans of Sierra Leone. J Coll Physicians Surg Pak. 2007;17:249–52.Google Scholar
  41. 41.
    Quarles FN, Johnson BA, Badreshia S, Vause SE, Brauner G, Breadon JY, Swinehart J, Lupo MP. Acne vulgaris in richly pigmented patients. Dermatol Ther. 2007;20:122–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Quarles FN, Brody H, Johnson BA, Badreshia S, Vause SE, Brauner G, Breadon JY, Swinehart J, Callendar V. Pseudofolliculitis barbae. Dermatol Ther. 2007;20:133–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Williams HC, Ashworth J, Pembroke AC, Breathnach SM. FACE-facial Afro-Caribbean childhood eruption. Clin Exp Dermatol. 1990;15:163–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Laude TA, Salvemini JN. Perioral dermatitis in children. Semin Cutan Med Surg. 1999;18:206–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Rauscher GE, Kolmer WL. Treatment of recurrent earlobe keloids. Cutis. 1986;37(1):67–8.PubMedGoogle Scholar
  46. 46.
    Alvarez MS, Silverberg NB. Tinea capitis. Cutis. 2006;78:189–96.PubMedGoogle Scholar
  47. 47.
    Sharma V, Silverberg NB, Howard R, Tran CT, Laude TA, Frieden IJ. Do hair care practices affect the acquisition of tinea capitis? A case-control study. Arch Pediatr Adolesc Med. 2001;155:818–21.PubMedGoogle Scholar
  48. 48.
    Silverberg NB, Weinberg JM, DeLeo VA. Tinea capitis: focus on African American women. J Am Acad Dermatol. 2002;46:S120–4.PubMedCrossRefGoogle Scholar
  49. 49.
    Lorch Dauk KC, Comrov E, Blumer JL, O’Riordan MA, Furman LM. Tinea capitis: predictive value of symptoms and time to cure with Griseofulvin treatment. Clin Pediatr (Phila). 2009 1 Jun. Epub ahead of print, Accessed 21Dec 2009.Google Scholar
  50. 50.
    Silverberg NB. Easy griseofulvin dosing. Pediatr Dermatol. 2008;25:577.PubMedCrossRefGoogle Scholar
  51. 51.
    Levin NA. Beyond spaghetti and meatballs: skin diseases associated with the Malassezia yeasts. Dermatol Nurs. 2009;21:7–13, 51.Google Scholar
  52. 52.
    Jin Y, Birlea SA, Fain PR, Spritz RA. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Investig Dermatol. 2007;127:2558–62.PubMedCrossRefGoogle Scholar
  53. 53.
    Silverberg NB, Travis L. Childhood vitiligo. Cutis. 2006;77(6):370–5.PubMedGoogle Scholar
  54. 54.
    Pagovich OE, Silverberg JI, Freilich E, Silverberg NB. Thyroid abnormalities in pediatric patients with vitiligo in New York City. Cutis. 2008;81:463–6.PubMedGoogle Scholar
  55. 55.
    Silverberg NB, Herz J, Wagner A, Paller AS. Erythema dyschromicum perstans in prepubertal children. Pediatr Dermatol. 2003;20:398–403.PubMedCrossRefGoogle Scholar
  56. 56.
    Torrelo A, Zaballos P, Colmenero I, Mediero IG, de Prada I, Zambrano A. Erythema dyschromicum perstans in children: a report of 14 cases. J Eur Acad Dermatol Venereol. 2005;19:422–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Shih IH, Lin JY, Chen CH, Hong HS. A birthmark survey in 500 newborns: clinical observation in two northern Taiwan medical center nurseries. Chang Gung Med J. 2007;30:220–5.PubMedGoogle Scholar
  58. 58.
    Rampen FH, de Wit PE. Racial differences in mole proneness. Acta Derm Venereol. 1989;69:234–6.PubMedGoogle Scholar
  59. 59.
    Hairston Jr MA, Reed RJ, Derbes VJ. Dermatosis papulosa nigra. Arch Dermatol. 1964;89:655–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Yesudian P, Thambiah A. Familial syringoma. Dermatologica. 1975;150(1):32–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Ferahbas A, Utas S, Ulas Y, Kontas O, Karakukcu M, Arseven V. Narrow band UVB treatment for a child with mycosis fungoides. Pediatr Dermatol. 2006;23:302–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients. J Am Acad Dermatol. 2000;42:33–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Mancini AJ, Frieden IJ, Paller AS. Infantile acropustulosis revisited: history of scabies and response to topical corticosteroids. Pediatr Dermatol. 1998;15:337–41.PubMedCrossRefGoogle Scholar
  64. 64.
    Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112(3 Pt 1):495–501.PubMedCrossRefGoogle Scholar
  65. 65.
    Epps RE. Case reports: selected dermatoses in children of color. J Drugs Dermatol. 2007;6:78–82.PubMedGoogle Scholar
  66. 66.
    Chang Y, Woo HY, Sung E, Kim CH, Kang H, Ju YS, Park KH. Prevalence of acanthosis nigricans in relation to anthropometric measures: community-based cross-sectional study in Korean pre-adolescent school children. Pediatr Int. 2008;50:667–73.PubMedCrossRefGoogle Scholar
  67. 67.
    Brickman WJ, Binns HJ, Jovanovic BD, Kolesky S, Mancini AJ, Metzger BE. Acanthosis nigricans: a common finding in overweight youth. Pediatr Dermatol. 2007;24:601–6.PubMedCrossRefGoogle Scholar
  68. 68.
    Ice CL, Murphy E, Minor VE, Neal WA. Metabolic syndrome in fifth grade children with acanthosis nigricans: results from the CARDIAC project. World J Pediatr. 2009;5:23–30.PubMedCrossRefGoogle Scholar
  69. 69.
    Sampaio MC, de Oliveira ZN, Machado MC, dos Reis VM, Vilela MA. Discoid lupus erythematosus in children–a retrospective study of 34 patients. Pediatr Dermatol. 2008;25:163–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Elish D, Silverberg NB. Neonatal lupus erythematosus. Cutis. 2006;77:82–6.PubMedGoogle Scholar
  71. 71.
    Kerr HA, Lim HW. Photodermatoses in African Americans: a retrospective analysis of 135 patients over a 7-year period. J Am Acad Dermatol. 2007;57:638–43.PubMedCrossRefGoogle Scholar
  72. 72.
    Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol. 2001;137:1429–34.PubMedGoogle Scholar
  73. 73.
    Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 2009;18(9):741–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Santiago Borrero PJ, Rodríguez-Pérez Y, Renta JY, Izquierdo NJ, Del Fierro L, Muñoz D, Molina NL, Ramírez S, Pagán-Mercado G, Ortíz I, Rivera-Caragol E, Spritz RA, Cadilla CL. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. J Investig Dermatol. 2006;126:85–90.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Pediatric and Adolescent DermatologySt. Luke’s Roosevelt Hospital Center and Columbia University College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations